{"transactions":[{"id":788348,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-07T20:32:54.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on May 1, 2027, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":100000,"derivative":{"exercise_price":8.63,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-26-000578","document":"e665445_4-mulroy.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000119380526000578/e665445_4-mulroy.xml","form_type":"4"}},{"id":941918,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-10T00:14:52.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":20100,"derivative":{"underlying":"Common Stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001276840-26-000006","document":"form4-01102026_120148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000006/form4-01102026_120148.xml","form_type":"4"}},{"id":941917,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-10T00:14:52.000Z","date":"2026-01-08","kind":"sale","planned":false,"acquired":false,"shares":2515,"price":44.71,"value":112445.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":21852,"source":{"system":"sec-edgar","filing":"0001276840-26-000006","document":"form4-01102026_120148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000006/form4-01102026_120148.xml","form_type":"4"}},{"id":941916,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-10T00:14:52.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":6700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":24367,"source":{"system":"sec-edgar","filing":"0001276840-26-000006","document":"form4-01102026_120148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000006/form4-01102026_120148.xml","form_type":"4"}},{"id":943099,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-08T21:08:58.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":29000,"derivative":{"exercise_price":43.91,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001276840-26-000004","document":"form4-01082026_090154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000004/form4-01082026_090154.xml","form_type":"4"}},{"id":943098,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-08T21:08:58.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":21400,"derivative":{"underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0001276840-26-000004","document":"form4-01082026_090154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000004/form4-01082026_090154.xml","form_type":"4"}},{"id":943097,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-08T21:08:58.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":false,"shares":5245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":5245,"derivative":{"underlying":"Common Stock","underlying_shares":5245},"source":{"system":"sec-edgar","filing":"0001276840-26-000004","document":"form4-01082026_090154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000004/form4-01082026_090154.xml","form_type":"4"}},{"id":943096,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T21:08:58.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":1908,"price":45.11,"value":86069.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":17667,"source":{"system":"sec-edgar","filing":"0001276840-26-000004","document":"form4-01082026_090154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000004/form4-01082026_090154.xml","form_type":"4"}},{"id":943095,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T21:08:58.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":true,"shares":5245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":19575,"source":{"system":"sec-edgar","filing":"0001276840-26-000004","document":"form4-01082026_090154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000004/form4-01082026_090154.xml","form_type":"4"}},{"id":945948,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-07T02:05:55.000Z","date":"2026-01-03","kind":"exercise","planned":false,"acquired":false,"shares":8292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":16585,"derivative":{"underlying":"Common Stock","underlying_shares":8292},"source":{"system":"sec-edgar","filing":"0001276840-26-000002","document":"form4-01072026_020152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000002/form4-01072026_020152.xml","form_type":"4"}},{"id":945947,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-07T02:05:55.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":3363,"price":43.26,"value":145483.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":14330,"source":{"system":"sec-edgar","filing":"0001276840-26-000002","document":"form4-01072026_020152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000002/form4-01072026_020152.xml","form_type":"4"}},{"id":945946,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-07T02:05:55.000Z","date":"2026-01-03","kind":"exercise","planned":false,"acquired":true,"shares":8292,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":17693,"source":{"system":"sec-edgar","filing":"0001276840-26-000002","document":"form4-01072026_020152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684026000002/form4-01072026_020152.xml","form_type":"4"}},{"id":959453,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-23T21:28:09.000Z","date":"2025-12-22","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 60,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 339,440 shares of common stock, which options vest according to their terms."}],"balance_after":60600,"derivative":{"exercise_price":20.16,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001276840-25-000004","document":"form4-12232025_091206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684025000004/form4-12232025_091206.xml","form_type":"4"}},{"id":959452,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-23T21:28:09.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":50,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 11, 2025."}],"balance_after":9401,"source":{"system":"sec-edgar","filing":"0001276840-25-000004","document":"form4-12232025_091206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684025000004/form4-12232025_091206.xml","form_type":"4"}},{"id":959451,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-23T21:28:09.000Z","date":"2025-12-22","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":20.16,"value":201600.0,"ownership":{"direct":true},"balance_after":19401,"source":{"system":"sec-edgar","filing":"0001276840-25-000004","document":"form4-12232025_091206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684025000004/form4-12232025_091206.xml","form_type":"4"}},{"id":962951,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-18T21:13:26.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"In addition to the remaining options to purchase 70,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 339,440 shares of common stock, which options vest according to their terms."}],"balance_after":70600,"derivative":{"exercise_price":20.16,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001276840-25-000003","document":"form4-12182025_091222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684025000003/form4-12182025_091222.xml","form_type":"4"}},{"id":962950,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T21:13:26.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":6360,"price":45.2062,"value":287511.432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.065 to $45.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9401,"source":{"system":"sec-edgar","filing":"0001276840-25-000003","document":"form4-12182025_091222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684025000003/form4-12182025_091222.xml","form_type":"4"}},{"id":962949,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T21:13:26.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":9365,"price":44.6152,"value":417821.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.07 to $45.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15761,"source":{"system":"sec-edgar","filing":"0001276840-25-000003","document":"form4-12182025_091222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684025000003/form4-12182025_091222.xml","form_type":"4"}},{"id":962948,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T21:13:26.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":20.16,"value":201600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the acquisition of 1,324 shares acquired under the Company's ESPP."}],"balance_after":25126,"source":{"system":"sec-edgar","filing":"0001276840-25-000003","document":"form4-12182025_091222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000127684025000003/form4-12182025_091222.xml","form_type":"4"}},{"id":1307759,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":76400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":76400,"derivative":{"exercise_price":14.83,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":76400},"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1307758,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":26800,"derivative":{"underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1307757,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-06","kind":"exercise","planned":false,"acquired":false,"shares":5245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":10490,"derivative":{"underlying":"Common Stock","underlying_shares":5245},"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1307756,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":false,"shares":8293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":24877,"derivative":{"underlying":"Common Stock","underlying_shares":8293},"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1307755,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":2054,"price":15.3,"value":31426.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes."}],"balance_after":13802,"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1307754,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-06","kind":"exercise","planned":false,"acquired":true,"shares":5245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":15856,"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1307753,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3407,"price":14.6,"value":49742.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes."}],"balance_after":10611,"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1307752,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T22:32:42.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":true,"shares":8293,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the acquisition of 981 shares acquired under the Company's ESPP."}],"balance_after":14018,"source":{"system":"sec-edgar","filing":"0001415889-25-001044","document":"form4-01072025_100138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588925001044/form4-01072025_100138.xml","form_type":"4"}},{"id":1404828,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-17T22:41:37.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"In addition to the remaining options to purchase 80,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 263,040 shares of common stock, which options vest according to their terms."}],"balance_after":80600,"derivative":{"exercise_price":20.16,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-023549","document":"form4-09172024_100933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924023549/form4-09172024_100933.xml","form_type":"4"}},{"id":1404827,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-09-17T22:41:37.000Z","date":"2024-09-14","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001415889-24-023549","document":"form4-09172024_100933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924023549/form4-09172024_100933.xml","form_type":"4"}},{"id":1404826,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T22:41:37.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":40.13,"value":401300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 14, 2024."}],"balance_after":4744,"source":{"system":"sec-edgar","filing":"0001415889-24-023549","document":"form4-09172024_100933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924023549/form4-09172024_100933.xml","form_type":"4"}},{"id":1404825,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T22:41:37.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":20.16,"value":201600.0,"ownership":{"direct":true},"balance_after":14744,"source":{"system":"sec-edgar","filing":"0001415889-24-023549","document":"form4-09172024_100933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924023549/form4-09172024_100933.xml","form_type":"4"}},{"id":1404824,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T22:41:37.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":2220,"price":38.93,"value":86424.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":4744,"source":{"system":"sec-edgar","filing":"0001415889-24-023549","document":"form4-09172024_100933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924023549/form4-09172024_100933.xml","form_type":"4"}},{"id":1404823,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T22:41:37.000Z","date":"2024-09-14","kind":"exercise","planned":true,"acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":6964,"source":{"system":"sec-edgar","filing":"0001415889-24-023549","document":"form4-09172024_100933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924023549/form4-09172024_100933.xml","form_type":"4"}},{"id":1449260,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-24T20:14:37.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics (\"Performance Metrics\"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026.  An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics (\"Performance Metrics\"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026.  An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-020034","document":"form4-07242024_080733.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924020034/form4-07242024_080733.xml","form_type":"4"}},{"id":1501714,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-24T20:12:25.000Z","date":"2024-05-22","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":23.72,"value":35580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of Common Stock acquired pursuant to the Issuer's Employee Stock Purchase Plan, for the purchase period through May 15, 2024."}],"balance_after":964,"source":{"system":"sec-edgar","filing":"0001415889-24-014463","document":"form4-05242024_080509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924014463/form4-05242024_080509.xml","form_type":"4"}},{"id":1663745,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-01T22:27:36.000Z","date":"2024-01-30","kind":"sale","planned":false,"acquired":false,"shares":3065,"price":23.6298,"value":72425.337,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.325 to $23.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":964,"source":{"system":"sec-edgar","filing":"0001415889-24-002204","document":"form4-02012024_100227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000141588924002204/form4-02012024_100227.xml","form_type":"4"}},{"id":1682464,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-10T00:06:27.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":false,"shares":5245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":15735,"derivative":{"underlying":"Common Stock","underlying_shares":5245},"source":{"system":"sec-edgar","filing":"0001209191-24-001278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919124001278/doc4.xml","form_type":"4"}},{"id":1682463,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-10T00:06:27.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":2180,"price":21.81,"value":47545.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":4029,"source":{"system":"sec-edgar","filing":"0001209191-24-001278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919124001278/doc4.xml","form_type":"4"}},{"id":1682462,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-10T00:06:27.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":true,"shares":5245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":6209,"source":{"system":"sec-edgar","filing":"0001209191-24-001278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919124001278/doc4.xml","form_type":"4"}},{"id":1685305,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-05T21:54:30.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":33170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":33170,"derivative":{"underlying":"Common Stock","underlying_shares":33170},"source":{"system":"sec-edgar","filing":"0001209191-24-001046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919124001046/doc4.xml","form_type":"4"}},{"id":1685304,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T21:54:30.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":90780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on January 3, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":90780,"derivative":{"exercise_price":21.19,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":90780},"source":{"system":"sec-edgar","filing":"0001209191-24-001046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919124001046/doc4.xml","form_type":"4"}},{"id":1778711,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-18T22:12:47.000Z","date":"2023-09-14","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-23-049808","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919123049808/doc4.xml","form_type":"4"}},{"id":1778710,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-18T22:12:47.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":3895,"price":19.3162,"value":75236.599,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.145 to $19.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":964,"source":{"system":"sec-edgar","filing":"0001209191-23-049808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919123049808/doc4.xml","form_type":"4"}},{"id":1778709,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-18T22:12:47.000Z","date":"2023-09-14","kind":"sale","planned":false,"acquired":false,"shares":2105,"price":19.48,"value":41005.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":4859,"source":{"system":"sec-edgar","filing":"0001209191-23-049808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919123049808/doc4.xml","form_type":"4"}},{"id":1778708,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-18T22:12:47.000Z","date":"2023-09-14","kind":"exercise","planned":false,"acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":6964,"source":{"system":"sec-edgar","filing":"0001209191-23-049808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919123049808/doc4.xml","form_type":"4"}},{"id":2057360,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-01-11T00:09:54.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":20980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":20980,"derivative":{"underlying":"Common Stock","underlying_shares":20980},"source":{"system":"sec-edgar","filing":"0001209191-23-002883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919123002883/doc4.xml","form_type":"4"}},{"id":2057359,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-11T00:09:54.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":57260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on January 6, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":57260,"derivative":{"exercise_price":23.23,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":57260},"source":{"system":"sec-edgar","filing":"0001209191-23-002883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919123002883/doc4.xml","form_type":"4"}},{"id":2157132,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-09-16T21:06:58.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents a one-time retention grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the total RSUs vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the total RSUs vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 12,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 215,600 shares of common stock, which options vest according to their terms, and (ii) 964 shares of common stock held directly."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-050350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919122050350/doc4.xml","form_type":"4"}},{"id":2221246,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T23:06:58.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 10, 2021, the reporting person was granted a performance-based option to purchase 10,000 shares of the Issuer's common stock, subject to the achievement of certain corporate performance criteria and the reporting person's continued service to the Issuer upon achievement thereof.  The performance criteria were achieved on the date in Column 3, resulting in the vesting of the entire award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 10,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 205,600 shares of common stock, which options vest according to their terms, and (ii) 964 shares of common stock held directly."}],"balance_after":10000,"derivative":{"exercise_price":29.7,"exercise_date":"2022-06-23","expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-039534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919122039534/doc4.xml","form_type":"4"}},{"id":2397490,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-14T21:45:17.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2023, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 70,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 135,600 shares of common stock, which options vest according to their terms, and (ii) 964 shares of common stock held directly."}],"balance_after":70000,"derivative":{"exercise_price":30.44,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-22-009329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919122009329/doc4.xml","form_type":"4"}},{"id":2506636,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-17T22:16:48.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":964,"price":22.03,"value":21236.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock acquired pursuant to the Issuer's Employee Stock Purchase Plan (\"ESPP\"), for the purchase period through November 15, 2021. In accordance with the ESPP, these shares were purchased at 85% of the lesser of the closing price of the Issuer's Common Stock on May 17, 2021 and November 15, 2021."}],"balance_after":964,"source":{"system":"sec-edgar","filing":"0001209191-21-065166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919121065166/doc4.xml","form_type":"4"}},{"id":2862706,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-13T02:27:32.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":45000,"derivative":{"exercise_price":29.7,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-21-010514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919121010514/doc4.xml","form_type":"4"}},{"id":3082516,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-07-15T21:04:57.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":90600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":90600,"derivative":{"exercise_price":20.16,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":90600},"source":{"system":"sec-edgar","filing":"0001209191-20-042505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276840/000120919120042505/doc4.xml","form_type":"4"}},{"id":3127882,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T16:03:04.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":82,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":82,"derivative":{"exercise_price":4.72,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":82},"source":{"system":"sec-edgar","filing":"0000920465-20-000083","document":"wf-form4_159112816720839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000083/wf-form4_159112816720839.xml","form_type":"4"}},{"id":3127881,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-02T16:03:04.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":82,"price":4.01,"value":328.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/29/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":5067,"source":{"system":"sec-edgar","filing":"0000920465-20-000083","document":"wf-form4_159112816720839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000083/wf-form4_159112816720839.xml","form_type":"4"}},{"id":3143833,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T16:05:58.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":56,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":56,"derivative":{"exercise_price":6.89,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":56},"source":{"system":"sec-edgar","filing":"0000920465-20-000076","document":"wf-form4_158991874112950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000076/wf-form4_158991874112950.xml","form_type":"4"}},{"id":3143832,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-19T16:05:58.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":56,"price":5.86,"value":328.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4985,"source":{"system":"sec-edgar","filing":"0000920465-20-000076","document":"wf-form4_158991874112950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000076/wf-form4_158991874112950.xml","form_type":"4"}},{"id":3164266,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-04T16:08:49.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":53,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":53,"derivative":{"exercise_price":7.26,"expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":53},"source":{"system":"sec-edgar","filing":"0000920465-20-000063","document":"wf-form4_158862290582559.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000063/wf-form4_158862290582559.xml","form_type":"4"}},{"id":3164265,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-04T16:08:49.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":53,"price":6.17,"value":327.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/30/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4929,"source":{"system":"sec-edgar","filing":"0000920465-20-000063","document":"wf-form4_158862290582559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000063/wf-form4_158862290582559.xml","form_type":"4"}},{"id":3174661,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-17T16:03:38.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":58,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":58,"derivative":{"exercise_price":6.6,"expiration_date":"2030-04-15","underlying":"Common Stock","underlying_shares":58},"source":{"system":"sec-edgar","filing":"0000920465-20-000051","document":"wf-form4_158715380065813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000051/wf-form4_158715380065813.xml","form_type":"4"}},{"id":3174660,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-17T16:03:38.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":58,"price":5.61,"value":325.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4876,"source":{"system":"sec-edgar","filing":"0000920465-20-000051","document":"wf-form4_158715380065813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000051/wf-form4_158715380065813.xml","form_type":"4"}},{"id":3312786,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-13T16:17:27.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":30000,"derivative":{"exercise_price":5.25,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000920465-20-000012","document":"wf-form4_157895022932210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000012/wf-form4_157895022932210.xml","form_type":"4"}},{"id":3324654,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T16:34:28.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":16,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":16,"derivative":{"exercise_price":3.93,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":16},"source":{"system":"sec-edgar","filing":"0000920465-20-000003","document":"wf-form4_157808725121090.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000003/wf-form4_157808725121090.xml","form_type":"4"}},{"id":3324653,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-03T16:34:28.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":16,"price":3.34,"value":53.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 12/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4818,"source":{"system":"sec-edgar","filing":"0000920465-20-000003","document":"wf-form4_157808725121090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000003/wf-form4_157808725121090.xml","form_type":"4"}},{"id":3339698,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T16:03:31.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":112,"derivative":{"exercise_price":3.35,"expiration_date":"2029-12-13","underlying":"Common Stock","underlying_shares":112},"source":{"system":"sec-edgar","filing":"0000920465-19-000174","document":"wf-form4_157661659450059.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000174/wf-form4_157661659450059.xml","form_type":"4"}},{"id":3339697,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-17T16:03:31.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":112,"price":2.85,"value":319.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 12/13/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4802,"source":{"system":"sec-edgar","filing":"0000920465-19-000174","document":"wf-form4_157661659450059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000174/wf-form4_157661659450059.xml","form_type":"4"}},{"id":3355006,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-03T16:27:45.000Z","date":"2019-11-29","kind":"grant","acquired":true,"shares":138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":138,"derivative":{"exercise_price":2.74,"expiration_date":"2029-11-29","underlying":"Common Stock","underlying_shares":138},"source":{"system":"sec-edgar","filing":"0000920465-19-000168","document":"wf-form4_157540844730842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000168/wf-form4_157540844730842.xml","form_type":"4"}},{"id":3355005,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-03T16:27:45.000Z","date":"2019-11-29","kind":"grant","acquired":true,"shares":138,"price":2.33,"value":321.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 11/29/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4690,"source":{"system":"sec-edgar","filing":"0000920465-19-000168","document":"wf-form4_157540844730842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000168/wf-form4_157540844730842.xml","form_type":"4"}},{"id":3366750,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-19T16:11:55.000Z","date":"2019-11-15","kind":"grant","acquired":true,"shares":62,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":62,"derivative":{"exercise_price":6.02,"expiration_date":"2029-11-15","underlying":"Common Stock","underlying_shares":62},"source":{"system":"sec-edgar","filing":"0000920465-19-000162","document":"wf-form4_157419790020747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000162/wf-form4_157419790020747.xml","form_type":"4"}},{"id":3366749,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-19T16:11:55.000Z","date":"2019-11-15","kind":"grant","acquired":true,"shares":62,"price":5.12,"value":317.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 11/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4552,"source":{"system":"sec-edgar","filing":"0000920465-19-000162","document":"wf-form4_157419790020747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000162/wf-form4_157419790020747.xml","form_type":"4"}},{"id":3380845,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-05T16:04:58.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":267,"derivative":{"exercise_price":7.02,"expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":267},"source":{"system":"sec-edgar","filing":"0000920465-19-000150","document":"wf-form4_157298788254421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000150/wf-form4_157298788254421.xml","form_type":"4"}},{"id":3380844,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-05T16:04:58.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":267,"price":5.96,"value":1591.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4490,"source":{"system":"sec-edgar","filing":"0000920465-19-000150","document":"wf-form4_157298788254421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000150/wf-form4_157298788254421.xml","form_type":"4"}},{"id":3392424,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-17T17:41:11.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":224,"derivative":{"exercise_price":8.38,"expiration_date":"2029-10-15","underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0000920465-19-000143","document":"wf-form4_157134842257231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000143/wf-form4_157134842257231.xml","form_type":"4"}},{"id":3392423,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-17T17:41:11.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":224,"price":7.12,"value":1594.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":4223,"source":{"system":"sec-edgar","filing":"0000920465-19-000143","document":"wf-form4_157134842257231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000143/wf-form4_157134842257231.xml","form_type":"4"}},{"id":3401778,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-02T17:05:46.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":213,"derivative":{"exercise_price":8.8,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":213},"source":{"system":"sec-edgar","filing":"0000920465-19-000136","document":"wf-form4_157005031693872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000136/wf-form4_157005031693872.xml","form_type":"4"}},{"id":3401777,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-02T17:05:46.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":213,"price":7.48,"value":1593.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 09/30/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3999,"source":{"system":"sec-edgar","filing":"0000920465-19-000136","document":"wf-form4_157005031693872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000136/wf-form4_157005031693872.xml","form_type":"4"}},{"id":3414329,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-16T19:24:30.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":171,"derivative":{"exercise_price":10.92,"expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":171},"source":{"system":"sec-edgar","filing":"0000920465-19-000128","document":"wf-form4_156867625577243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000128/wf-form4_156867625577243.xml","form_type":"4"}},{"id":3414328,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-16T19:24:30.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":171,"price":9.28,"value":1586.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 09/13/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3786,"source":{"system":"sec-edgar","filing":"0000920465-19-000128","document":"wf-form4_156867625577243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000128/wf-form4_156867625577243.xml","form_type":"4"}},{"id":3425251,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-03T16:13:07.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":196,"derivative":{"exercise_price":9.57,"expiration_date":"2029-08-30","underlying":"Common Stock","underlying_shares":196},"source":{"system":"sec-edgar","filing":"0000920465-19-000121","document":"wf-form4_156754156886073.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000121/wf-form4_156754156886073.xml","form_type":"4"}},{"id":3425250,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-03T16:13:07.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":196,"price":8.13,"value":1593.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 08/30/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3615,"source":{"system":"sec-edgar","filing":"0000920465-19-000121","document":"wf-form4_156754156886073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000121/wf-form4_156754156886073.xml","form_type":"4"}},{"id":3436730,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-16T16:50:40.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":198,"derivative":{"exercise_price":9.43,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":198},"source":{"system":"sec-edgar","filing":"0000920465-19-000110","document":"wf-form4_156598862430306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000110/wf-form4_156598862430306.xml","form_type":"4"}},{"id":3436729,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-16T16:50:40.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":198,"price":8.02,"value":1587.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 08/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3419,"source":{"system":"sec-edgar","filing":"0000920465-19-000110","document":"wf-form4_156598862430306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000110/wf-form4_156598862430306.xml","form_type":"4"}},{"id":3449932,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T16:59:59.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":224,"derivative":{"exercise_price":8.36,"expiration_date":"2029-07-31","underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0000920465-19-000105","document":"wf-form4_156477958390697.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000105/wf-form4_156477958390697.xml","form_type":"4"}},{"id":3449931,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-02T16:59:59.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":224,"price":7.11,"value":1592.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 07/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3221,"source":{"system":"sec-edgar","filing":"0000920465-19-000105","document":"wf-form4_156477958390697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000105/wf-form4_156477958390697.xml","form_type":"4"}},{"id":3460288,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-17T17:11:05.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":203,"derivative":{"exercise_price":9.24,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000920465-19-000098","document":"wf-form4_156339784958788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000098/wf-form4_156339784958788.xml","form_type":"4"}},{"id":3460287,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-17T17:11:05.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":203,"price":7.85,"value":1593.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 07/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2997,"source":{"system":"sec-edgar","filing":"0000920465-19-000098","document":"wf-form4_156339784958788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000098/wf-form4_156339784958788.xml","form_type":"4"}},{"id":3475161,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-01T18:12:06.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":202,"derivative":{"exercise_price":9.25,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":202},"source":{"system":"sec-edgar","filing":"0000920465-19-000094","document":"wf-form4_156201911135934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000094/wf-form4_156201911135934.xml","form_type":"4"}},{"id":3475160,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-01T18:12:06.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":202,"price":7.86,"value":1587.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 06/28/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2794,"source":{"system":"sec-edgar","filing":"0000920465-19-000094","document":"wf-form4_156201911135934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000094/wf-form4_156201911135934.xml","form_type":"4"}},{"id":3486800,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T16:44:51.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":193,"derivative":{"exercise_price":9.71,"expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":193},"source":{"system":"sec-edgar","filing":"0000920465-19-000089","document":"wf-form4_156089067598117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000089/wf-form4_156089067598117.xml","form_type":"4"}},{"id":3486799,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-18T16:44:51.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":193,"price":8.25,"value":1592.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 06/14/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2592,"source":{"system":"sec-edgar","filing":"0000920465-19-000089","document":"wf-form4_156089067598117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000089/wf-form4_156089067598117.xml","form_type":"4"}},{"id":3505495,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-03T19:26:18.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":347,"derivative":{"exercise_price":5.39,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":347},"source":{"system":"sec-edgar","filing":"0000920465-19-000083","document":"wf-form4_155960436247457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000083/wf-form4_155960436247457.xml","form_type":"4"}},{"id":3505494,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-03T19:26:18.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":347,"price":4.58,"value":1589.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2399,"source":{"system":"sec-edgar","filing":"0000920465-19-000083","document":"wf-form4_155960436247457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000083/wf-form4_155960436247457.xml","form_type":"4"}},{"id":3522199,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T16:06:07.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":285,"derivative":{"exercise_price":6.57,"expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":285},"source":{"system":"sec-edgar","filing":"0000920465-19-000079","document":"wf-form4_155812355260353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000079/wf-form4_155812355260353.xml","form_type":"4"}},{"id":3522198,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-17T16:06:07.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":285,"price":5.58,"value":1590.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2052,"source":{"system":"sec-edgar","filing":"0000920465-19-000079","document":"wf-form4_155812355260353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000079/wf-form4_155812355260353.xml","form_type":"4"}},{"id":3542927,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-02T17:12:24.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":233,"derivative":{"exercise_price":8.05,"expiration_date":"2029-04-30","underlying":"Common Stock","underlying_shares":233},"source":{"system":"sec-edgar","filing":"0000920465-19-000071","document":"wf-form4_155683152923189.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000071/wf-form4_155683152923189.xml","form_type":"4"}},{"id":3542926,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-02T17:12:24.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":233,"price":6.84,"value":1593.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/30/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1767,"source":{"system":"sec-edgar","filing":"0000920465-19-000071","document":"wf-form4_155683152923189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000071/wf-form4_155683152923189.xml","form_type":"4"}},{"id":3554460,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T17:02:28.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":261,"derivative":{"exercise_price":7.16,"expiration_date":"2029-04-15","underlying":"Common Stock","underlying_shares":261},"source":{"system":"sec-edgar","filing":"0000920465-19-000061","document":"wf-form4_155553493410654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000061/wf-form4_155553493410654.xml","form_type":"4"}},{"id":3554459,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:02:28.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":261,"price":6.09,"value":1589.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1534,"source":{"system":"sec-edgar","filing":"0000920465-19-000061","document":"wf-form4_155553493410654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000061/wf-form4_155553493410654.xml","form_type":"4"}},{"id":3570175,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T19:07:54.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":59,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":59,"derivative":{"exercise_price":6.43,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":59},"source":{"system":"sec-edgar","filing":"0000920465-19-000058","document":"wf-form4_155424645767599.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000058/wf-form4_155424645767599.xml","form_type":"4"}},{"id":3570174,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":49080,"kind":"person","name":"MULROY DENNIS","position":1,"cik":"0001276840","reported_name":"MULROY DENNIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-02T19:07:54.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":59,"price":5.47,"value":322.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 03/29/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1273,"source":{"system":"sec-edgar","filing":"0000920465-19-000058","document":"wf-form4_155424645767599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000058/wf-form4_155424645767599.xml","form_type":"4"}}],"next_cursor":"2019-04-02T19:07:54.000000Z,3570174"}